David Gruben
Impact in
- Rheumatology top 0.05%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 0.2%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 74
- Rheumatoid Arthritis Research and Therapies 68
- Systemic Lupus Erythematosus Research 16
- Spondyloarthritis Studies and Treatments 7
- Hematology 45
- Autoimmune and Inflammatory Disorders Research 45
- Co-authors
- Samuel H. Zwillich (36 shared papers)Gene V. Wallenstein (30 shared papers)Sriram Krishnaswami (16 shared papers)Roy Fleischmann (22 shared papers)John Bradley (22 shared papers)Joel M. Kremer (18 shared papers)Bethanie Wilkinson (19 shared papers)Tamás Koncz (15 shared papers)
- Journals
- Annals of the Rheumatic Diseases (26 papers)Rheumatology and Therapy (5 papers)Dermatology and Therapy (4 papers)Arthritis Research & Therapy (4 papers)Arthritis Care & Research (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
David Gruben
97 papers receiving 6.1k citations
David Gruben's Hit Papers
Peers
Comparison fields: 5 of 122
- Rheumatology 4.4k
- Hematology 2.5k
- Genetics 1.4k
- Immunology 1.5k
- Oncology 1.4k
Countries citing papers authored by David Gruben
This map shows the geographic impact of David Gruben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Gruben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Gruben more than expected).
Fields of papers citing papers by David Gruben
This network shows the impact of papers produced by David Gruben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Gruben. The network helps show where David Gruben may publish in the future.
Co-authors
The 25 scholars most cited alongside David Gruben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis Hit paper breakdown → | 2012 | 790 |
| 2 | Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis Hit paper breakdown → | 2012 | 739 |
| 3 | Tofacitinib versus Methotrexate in Rheumatoid Arthritis Hit paper breakdown → | 2014 | 598 |
| 4 | Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial Hit paper breakdown → | 2013 | 548 |
| 5 | Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study Hit paper breakdown → | 2013 | 456 |
| 6 | 2009 | 440 | |
| 7 | Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis Hit paper breakdown → | 2013 | 366 |
| 8 | 2011 | 315 | |
| 9 | 2011 | 284 | |
| 10 | 2014 | 253 | |
| 11 | 2013 | 174 | |
| 12 | 2009 | 116 | |
| 13 | 2019 | 70 | |
| 14 | 2016 | 60 | |
| 15 | 2016 | 57 | |
| 16 | 2015 | 50 | |
| 17 | 2016 | 50 | |
| 18 | 2014 | 49 | |
| 19 | 2020 | 45 | |
| 20 | Ethnic differences in anthropometric characteristics of young children and their parents. | 1989 | 43 |
About David Gruben
David Gruben is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 101 papers that have together received 6.3k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (68 papers), Autoimmune and Inflammatory Disorders Research (45 papers), Chronic Lymphocytic Leukemia Research (19 papers), Systemic Lupus Erythematosus Research (16 papers), Biosimilars and Bioanalytical Methods (13 papers), Lymphoma Diagnosis and Treatment (9 papers), Inflammatory Bowel Disease (9 papers) and Spondyloarthritis Studies and Treatments (7 papers). The work is most often cited by research in Rheumatology (4.4k citations), Hematology (2.5k citations), Genetics (1.4k citations), Immunology (1.5k citations) and Oncology (1.4k citations). David Gruben has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Samuel H. Zwillich, Gene V. Wallenstein, Sriram Krishnaswami, Roy Fleischmann, John Bradley, Joel M. Kremer, Bethanie Wilkinson, Tamás Koncz, Carol A. Connell and Eun Bong Lee. Their work appears in journals such as Annals of the Rheumatic Diseases, Rheumatology and Therapy, Dermatology and Therapy, Arthritis Research & Therapy and Arthritis Care & Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.